A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
- PMID: 20176003
- DOI: 10.1016/j.brainres.2010.02.045
A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
Abstract
Dysfunction of the ubiquitin-proteasome system (UPS) occurs in dopaminergic neurones in the SN in PD and it is associated with Lewy body formation. However, it remains unknown whether this is specific to PD or whether it also occurs in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) where nigral dopaminergic neurones also degenerate. In the present study, we investigated changes in the expression of proteasomal subunits in the SN in PD, MSA and PSP. Immunohistochemistry double staining showed that proteasome 20S-alpha4 and -alpha6, and 20S-beta3 and -beta5i subunits are colocalized with tyrosine hydroxylase (TH)-positive cells in the SN of control, PD, MSA and PSP brain. Semi-quantitative analysis showed a significant loss of 20S-alpha4 and -alpha6 subunits TH-positive cells in PD, MSA and PSP compared to control tissue. There was no change in the expression of 20S-beta3 and -beta5i subunits in any of the disease states. The expression of PA700-Rpt5 subunits was not changed in PSP or PD but was significantly increased in MSA compared to control SN. PA700-Rpn10 subunit was not colocalized with TH within dopamine cells but was co-expressed with glial fibrillary acid protein (GFAP) positive astrocytes in the SN of all groups. PA28-alpha immunoreactivity was low in TH positive neurones in control tissue and quantification was not possible. Qualitative analysis suggested a decrease in PD and no immunoreactivity was detected in MSA or PSP. The results show that changes in proteasomal structure occur in the SN in PD, MSA and PSP and that these are similar in nature suggesting that dysfunction of UPS is not specific to PD or to Lewy body formation.
Copyright 2010 Elsevier B.V. All rights reserved.
Similar articles
-
MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome.Eur J Neurosci. 2006 Apr;23(7):1766-74. doi: 10.1111/j.1460-9568.2006.04718.x. Eur J Neurosci. 2006. PMID: 16623833
-
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10. Brain. 2010. PMID: 19903734
-
Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.Mov Disord. 1998 Mar;13(2):221-7. doi: 10.1002/mds.870130205. Mov Disord. 1998. PMID: 9539333
-
Coexistence of PSP and MSA: a case report and review of the literature.Acta Neuropathol. 2006 Feb;111(2):186-92. doi: 10.1007/s00401-005-0022-z. Epub 2006 Feb 3. Acta Neuropathol. 2006. PMID: 16456665 Review.
-
Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.Mov Disord. 2016 May;31(5):684-92. doi: 10.1002/mds.26584. Epub 2016 Mar 17. Mov Disord. 2016. PMID: 26990970 Review.
Cited by
-
Dopaminergic neurons show increased low-molecular-mass protein 7 activity induced by 6-hydroxydopamine in vitro and in vivo.Transl Neurodegener. 2018 Aug 17;7:19. doi: 10.1186/s40035-018-0125-9. eCollection 2018. Transl Neurodegener. 2018. PMID: 30128145 Free PMC article.
-
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets.Signal Transduct Target Ther. 2023 Sep 22;8(1):359. doi: 10.1038/s41392-023-01588-0. Signal Transduct Target Ther. 2023. PMID: 37735487 Free PMC article. Review.
-
Animal modeling an oligodendrogliopathy--multiple system atrophy.Acta Neuropathol Commun. 2016 Feb 9;4:12. doi: 10.1186/s40478-016-0279-6. Acta Neuropathol Commun. 2016. PMID: 26860328 Free PMC article. Review.
-
Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential.Mol Neurodegener. 2023 Nov 11;18(1):83. doi: 10.1186/s13024-023-00676-7. Mol Neurodegener. 2023. PMID: 37951933 Free PMC article. Review.
-
Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein.Acta Neuropathol Commun. 2020 Feb 14;8(1):17. doi: 10.1186/s40478-020-0894-0. Acta Neuropathol Commun. 2020. PMID: 32059750 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous